Department of Pediatric Surgery, All India Institute of Medical Sciences, New Delhi, 110029, India.
Department of Pediatric Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Indian J Pediatr. 2022 Oct;89(10):968-974. doi: 10.1007/s12098-021-04016-9. Epub 2022 Jan 8.
To evaluate the role of diffusion-weighted magnetic resonance imaging (DW-MR) in hepatoblastoma as compared to multiphase contrast enhanced computed tomography (CECT) scans for detection of satellite lesions.
In this prospective study on new cases of hepatoblastoma, multiphase CECT scans and DW-MR were performed before initiation of chemotherapy. Results of interpretation were compared for detection of satellite lesions. PRETEXT grouping and risk categorization was done according to SIOPEL based on CECT scan.
Nine boys and 1 girl with hepatoblastoma, with median age of 11.5 mo were included. All patients were stratified as high-risk group with 2 (20%) in PRETEXT II and 8 (80%) in PRETEXT III. In 2 of 10 (20%) patients, additional satellite lesions were detected on DW-MR, which upgraded their stage. One of the two patients had one satellite lesion identified on CECT, while additional seven satellite lesions were identified on DW-MR imaging. For the other patient, CECT showed no satellite lesion while DW-MR detected six satellite lesions.
MRI has become the gold standard investigation for evaluation of hepatoblastoma. DW-MR, which is a contrast free technique, is a better tool for assessment of satellite lesions which are usually missed on CECT. This would help in proper staging, planning of management and prognostication.
与多期对比增强 CT(CECT)扫描相比,评估弥散加权磁共振成像(DW-MRI)在肝母细胞瘤中检测卫星病变的作用。
在这项新的肝母细胞瘤病例的前瞻性研究中,在开始化疗前进行多期 CECT 扫描和 DW-MRI。比较解释结果以检测卫星病变。根据 CECT 扫描,根据 SIOPEL 进行 PRETEXT 分组和风险分类。
纳入 9 名男孩和 1 名女孩,肝母细胞瘤,中位年龄 11.5 个月。所有患者均按高危分层,2 例(20%)为 PRETEXT II,8 例(80%)为 PRETEXT III。在 10 例患者中的 2 例中,DW-MR 检测到额外的卫星病变,这使他们的分期升级。其中 1 例患者在 CECT 上发现 1 个卫星病变,而在 DW-MR 成像上发现了另外 7 个卫星病变。另一位患者 CECT 无卫星病变,DW-MR 发现 6 个卫星病变。
MRI 已成为肝母细胞瘤评估的金标准检查。DW-MR 是一种无对比剂技术,是评估通常在 CECT 上漏诊的卫星病变的更好工具。这将有助于正确分期、制定管理计划和预测预后。